Skip to main content
Equibles

VANGUARD PORTFOLIO MANAGEMENT LLC

Position in MYGN — Myriad Genetics Inc

CIK 2100121 MALVERN, PA
Back to MYGN Full portfolio

Position in MYGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$17,584,915
+$5,964,876 QoQ
Shares Held
3,079,670
+19.3% QoQ
Ownership
3.22%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 196 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

VANGUARD PORTFOLIO MANAGEMENT LLC holds $22,945,604,526 across 31 Diagnostics & Research names. MYGN ranks #25 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 6,226,169 $3,121,552,089
2 DHR
Danaher Corp /De/
 14,205,213 $2,705,808,972
3 IDXX
Idexx Laboratories Inc /De
 3,896,521 $2,051,284,515
4 A
Agilent Technologies, Inc.
 14,442,441 $1,918,389,438
5 WAT
Waters Corp /De/
 4,740,524 $1,777,886,120
6 NTRA
Natera, Inc.
 5,782,640 $1,569,697,628
7 IQV
Iqvia Holdings Inc.
 7,501,993 $1,449,535,087
8 DGX
Quest Diagnostics Inc
 6,131,045 $1,299,474,987

All Filings in MYGN

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,584,915 3,079,670
2026-03-31 $11,620,039 2,582,231